Sort
48,018 grants matching “immunotherapy”
TARGETED IMMUNOTHERAPY FOR MELANOMA
$528,801Georgia Tech Research Corp · · FY2016 · Department of the Army
Efficacious and safe antibody catalyzed amyloid beta clearance
$528,773Sudhir Paul · University Of Texas Hlth Sci Ctr Houston · U01 · FY2010 · AG
UNIVERSITY OF MARYLAND GREENEBAUM CANCER CENTER SUPPORT GRANT
$528,762Kevin J Cullen · University Of Maryland Baltimore · P30 · FY2020 · CA
Immunosurveillance and Immunopathology Core
$528,724Sabarinathan Ramachandran · University Of Minnesota · U19 · FY2023 · AI
Mechanisms of Murine Tumor Eradication by Immunotherapy
$528,643Philip D Greenberg · University Of Washington · R01 · FY2007 · CA
Antigenic determinants of asthma-associated allergens for design of immunotherapy
$528,625Anna Pomes · Indoor Biotechnologies · R01 · FY2024 · AI
Matrix assembly and remodeling during S. aureus biofilm development
$528,502Kenneth W. Bayles · University Of Nebraska Medical Center · P01 · FY2015 · AI
Role of immune receptor clustering in controlling efficacy of antibody-dependent FcγRIIIa-mediated cytotoxicity by NK cells
$528,500Yuri Sykulev · Thomas Jefferson University · U01 · FY2020 · AI
Imaging-guided fine tuning of CAR T cell affinity to limit T cell cytotoxicity to tumor antigen
$528,498Moonsoo M. Jin · Weill Medical Coll Of Cornell Univ · R01 · FY2021 · CA
Imaging-guided fine tuning of CAR T cell affinity to limit T cell cytotoxicity to tumor antigen
$528,498Moonsoo M. Jin · Weill Medical Coll Of Cornell Univ · R01 · FY2020 · CA
Regulatory T cells in Autoimmune Disease
$528,485Charles Garrison Fathman · Brigham And Women'S Hospital · U19 · FY2008 · AI
Sunitinib Modulation of Cancer Immunotherapy
$528,446James H Finke · Cleveland Clinic Lerner Com-Cwru · R01 · FY2012 · CA
Targeting PD-L1 interactome signaling to enhance immunotherapy efficacy in head and neck squamous cell cancer
$528,427Antonio Jimeno · University Of Colorado Denver · R01 · FY2025 · CA
Plasmonic nanoparticle-mediated immunotherapy to treat metastatic cancer
$528,416Tuan Vo-Dinh · Duke University · R01 · FY2022 · EB
Epigenomic Mechanisms & Contextual Immunity in Persistent MRSA Bacteremia
$528,279Michael R Yeaman · Lundquist Institute For Biomedical Innovation At Harbor-Ucla Medical Center · U19 · FY2023 · AI
Mechanisms of Antigen-Induced Tolerance in the Lung
$528,200Anuradha Ray · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · AI
Persistent STAT5 signaling in polyfunctional CD4 T cells and its application in adoptive T cell therapy
$528,183Gang Zhou · Augusta University · R01 · FY2021 · CA
Identifying cell surface targets for innovative immunotherapy of Multiple Myeloma
$528,175Fabiana Perna · H. Lee Moffitt Cancer Ctr & Res Inst · R37 · FY2024 · CA
Molecular Genetics
$528,163Carlo M Croce · University Of California, San Diego · P01 · FY2014 · CA
TCR-antigen foundation model to empower TCR-based diagnostics and therapeutics
$528,157Tao Wang · University Of Tx Md Anderson Can Ctr · R01 · FY2025 · AI
Metabolic Control of Immune Suppression in Gliomas
$528,130Maciej S Lesniak · University Of Chicago · R01 · FY2015 · NS
Nanoscale delivery vehicles for antigen-based vaccines
$528,113University Of California Berkeley · R01 · FY2005 · EB
Nano and biomolecular engineered technologies for neoantigen-specific T cell capture and characterization
$528,041James R. Heath · Institute For Systems Biology · R01 · FY2023 · CA
Targeting PIM-2 Kinase for Improving Cancer Immunotherapy
$528,033Xue-Zhong Yu · Medical College Of Wisconsin · R01 · FY2023 · CA
Targeting gasdermin D to treat myelodysplastic syndromes
$527,987Peng Ji · Northwestern University At Chicago · R01 · FY2024 · HL